Akebia Therapeutics, Inc. (AKBA)

Akebia Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	34.02	42.93	90.47	149.8	228.7	147.45
Short-Term Investments	-	-	-	-	39.99	0.25
Cash & Short-Term Investments	34.02	42.93	90.47	149.8	268.69	147.69
Cash Growth	-26.89%	-52.55%	-39.61%	-44.25%	81.92%	-54.08%
Accounts Receivable	32.17	39.29	40.28	55.89	28.58	38.86
Receivables	32.17	39.29	40.28	55.89	28.58	38.86
Inventory	20.49	15.69	21.57	36.63	61.02	116.35
Prepaid Expenses	7.23	14.49	15.62	28.83	12.76	6.36
Restricted Cash	-	-	-	-	0.4	0.26
Other Current Assets	6.21	5.75	17.25	-	-	-
Total Current Assets	100.12	118.15	185.18	271.15	371.44	309.53
Property, Plant & Equipment	11.83	16.05	34.37	40.61	35.5	39.42
Goodwill	59.04	59.04	59.04	59.04	55.05	55.05
Other Intangible Assets	9.01	36.04	72.08	108.13	144.17	291.21
Other Long-Term Assets	27.13	12.42	5.37	50.42	37.98	75.99
Total Assets	207.14	241.7	356.05	529.35	644.14	771.2
Accounts Payable	13.49	14.64	18.02	33.59	41.31	39.22
Accrued Expenses	28.17	42.94	53.92	97.51	125.34	124.08
Current Portion of Long-Term Debt	2.24	19.55	32	97.54	-	-
Current Portion of Leases	5.29	4.49	4.74	4.8	5.29	4.99
Current Unearned Revenue	-	-	3.74	20.91	15.21	39.83
Other Current Liabilities	16.52	18.26	17.12	6.7	-	-
Total Current Liabilities	65.71	99.87	129.54	261.05	187.15	208.12
Long-Term Debt	90.74	71.2	91.56	53.08	96.38	75.81
Long-Term Leases	4.94	8.95	28.96	33.7	24.62	27.53
Long-Term Unearned Revenue	-	43.3	43.3	21.47	25.35	33.12
Other Long-Term Liabilities	96.16	48.98	57.47	86.03	63.03	31.87
Total Liabilities	257.54	272.29	350.82	455.34	396.52	376.44
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	1,605	1,578	1,562	1,537	1,425	1,189
Retained Earnings	-1,656	-1,609	-1,557	-1,463	-1,178	-794.05
Comprehensive Income & Other	0.01	0.01	0.01	0.01	0.01	-
Total Common Equity	-50.4	-30.58	5.23	74.01	247.62	394.76
Shareholders' Equity	-50.4	-30.58	5.23	74.01	247.62	394.76
Total Liabilities & Equity	207.14	241.7	356.05	529.35	644.14	771.2
Total Debt	103.2	104.18	157.27	189.13	126.29	108.32
Net Cash (Debt)	-69.18	-61.26	-66.8	-39.33	142.41	39.37
Net Cash Growth	-	-	-	-	261.69%	-87.16%
Net Cash Per Share	-0.34	-0.33	-0.37	-0.24	1.03	0.33
Filing Date Shares Outstanding	218.18	209.37	184.25	181.23	153.5	129.86
Total Common Shares Outstanding	211.54	194.58	184.14	177	148.07	121.67
Working Capital	34.41	18.28	55.65	10.1	184.29	101.42
Book Value Per Share	-0.24	-0.16	0.03	0.42	1.67	3.24
Tangible Book Value	-118.46	-125.67	-125.9	-93.16	48.4	48.49
Tangible Book Value Per Share	-0.56	-0.65	-0.68	-0.53	0.33	0.40
Machinery	-	-	-	5.85	5.79	5.55
Leasehold Improvements	-	-	-	8.57	8.57	8.5

Source: S&P Capital IQ. Standard template. Financial Sources.